VERRICA PHARMACEUTICALS INC (VRCA) Stock Analyst Ratings
USA - NASDAQ:VRCA - US92511W2070 - Common Stock
3.85 USD
-0.1 (-2.53%)
3.81 USD
-0.04 (-1.04%)
ChartMill assigns a Buy % Consensus number of 78% to VRCA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 15.3. This target is 297.4% above the current price.
VRCA was analyzed by 11 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about VRCA.
In the previous month the buy percentage consensus was at a similar level.
VRCA was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-14 | Needham | Reiterate | Hold -> Hold |
| 2025-04-09 | Needham | Reiterate | Hold -> Hold |
| 2025-04-08 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-03-12 | Needham | Reiterate | Hold -> Hold |
| 2024-12-20 | Needham | Reiterate | Hold -> Hold |
| 2024-11-06 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-11-05 | Needham | Reiterate | Hold |
| 2024-11-05 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2024-10-21 | TD Cowen | Maintains | Buy -> Buy |
| 2024-10-04 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-10-03 | Needham | Downgrade | Buy -> Hold |
| 2024-10-02 | Brookline Capital | Downgrade | Buy -> Hold |
| 2024-08-15 | Needham | Maintains | Buy -> Buy |
| 2024-08-15 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-05-16 | Needham | Reiterate | Buy -> Buy |
| 2024-05-14 | Needham | Maintains | Buy -> Buy |
| 2024-05-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-04-10 | Needham | Reiterate | Buy -> Buy |
| 2024-03-01 | Needham | Reiterate | Buy -> Buy |
| 2024-03-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-12-15 | Jefferies | Reiterate | Buy -> Buy |
| 2023-11-10 | Needham | Maintains | Buy -> Buy |
| 2023-10-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-23 | Needham | Reiterate | Buy -> Buy |
| 2023-08-10 | Needham | Reiterate | Buy -> Buy |
| 2023-07-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-07-25 | Needham | Upgrade | Hold -> Buy |
| 2023-07-25 | RBC Capital | Maintains | Outperform -> Outperform |
| 2023-07-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-03-22 | Jefferies | Initiate | Buy |
VERRICA PHARMACEUTICALS INC / VRCA FAQ
What is the average price target for VERRICA PHARMACEUTICALS INC (VRCA) stock?
11 analysts have analysed VRCA and the average price target is 15.3 USD. This implies a price increase of 297.4% is expected in the next year compared to the current price of 3.85.
Can you provide the consensus rating for VERRICA PHARMACEUTICALS INC stock?
The consensus rating for VERRICA PHARMACEUTICALS INC (VRCA) is 78.1818 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover VERRICA PHARMACEUTICALS INC (VRCA) stock?
The number of analysts covering VERRICA PHARMACEUTICALS INC (VRCA) is 11.